ORGO Earnings & Financial Statements
Organogenesis Holdings Inc.
$1.11
-$0.03(-2.63%)
41
Overall
70
Value
18
Tech
36
Quality
Market Cap
$146.69M
Volume
782.57K
52W Range
$1.25 - $7.08
Target Price
$2.00
ORGO earnings and financial statements: Organogenesis Holdings Inc.'s income statement, balance sheet and cash flow statement, annual and quarterly.
ORGO Annual Financial Statements
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $564.17M | $482.04M | $433.14M | $450.89M | $467.36M |
| Cost of revenue | $137.52M | $115.74M | $106.48M | $105.02M | $114.20M |
| Operating income | $44.69M | -$1.28M | $12.53M | $22.30M | $72.22M |
| EBITDA | $71.63M | $24.11M | $36.03M | $40.32M | $87.00M |
| Net income | $37.03M | $861.0K | $4.95M | $15.53M | $94.20M |
| EPS (diluted) | $0.15 | $-0.01 | $0.04 | $0.12 | $0.71 |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | $598.73M | $497.89M | $460.02M | $449.36M | $443.26M |
| Total liabilities | $164.81M | $112.57M | $181.36M | $183.69M | $201.92M |
| Shareholders’ equity | $300.13M | $262.90M | $278.66M | $265.67M | $241.34M |
| Cash and equivalents | $93.68M | $135.57M | $103.84M | $102.48M | $113.93M |
| Long-term debt | $35.26M | $25.92M | $87.69M | $87.18M | $117.66M |
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Operating cash flow | -$10.31M | $14.21M | $30.92M | $24.86M | $61.98M |
| Capital expenditure | -$14.15M | -$10.03M | -$24.36M | -$33.90M | -$31.22M |
| Free cash flow | -$24.46M | $4.18M | $6.55M | -$9.04M | $30.76M |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | ORGO | $1.11 | -2.6% | 782.57K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Organogenesis Holdings Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW